9,985 Shares in CVS Health Corporation $CVS Acquired by Net Worth Advisory Group

Net Worth Advisory Group acquired a new stake in CVS Health Corporation (NYSE:CVS) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 9,985 shares of the pharmacy operator’s stock, valued at approximately $792,000.

A number of other institutional investors also recently modified their holdings of CVS. Capital World Investors raised its holdings in CVS Health by 2.1% during the third quarter. Capital World Investors now owns 68,382,158 shares of the pharmacy operator’s stock worth $5,155,380,000 after buying an additional 1,419,575 shares during the last quarter. State Street Corp increased its position in shares of CVS Health by 0.3% during the third quarter. State Street Corp now owns 58,938,286 shares of the pharmacy operator’s stock worth $4,443,357,000 after acquiring an additional 149,701 shares in the last quarter. Capital International Investors raised its holdings in shares of CVS Health by 1.1% in the 3rd quarter. Capital International Investors now owns 26,692,203 shares of the pharmacy operator’s stock worth $2,012,347,000 after acquiring an additional 302,499 shares during the last quarter. Invesco Ltd. lifted its position in CVS Health by 3.2% in the 3rd quarter. Invesco Ltd. now owns 24,293,058 shares of the pharmacy operator’s stock valued at $1,831,454,000 after acquiring an additional 760,579 shares in the last quarter. Finally, Capital Research Global Investors boosted its stake in CVS Health by 24.5% during the 3rd quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock valued at $864,667,000 after purchasing an additional 2,253,531 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CVS has been the subject of several analyst reports. UBS Group reissued an “outperform” rating on shares of CVS Health in a research note on Wednesday, December 10th. JPMorgan Chase & Co. lifted their target price on CVS Health from $93.00 to $101.00 and gave the company an “overweight” rating in a research report on Wednesday, December 17th. Piper Sandler reissued an “overweight” rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Robert W. Baird raised their price objective on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Finally, Barclays upped their target price on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.05.

CVS Health Price Performance

Shares of NYSE CVS opened at $70.08 on Friday. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock has a fifty day simple moving average of $76.62 and a two-hundred day simple moving average of $77.77. The firm has a market cap of $89.16 billion, a price-to-earnings ratio of 50.79, a price-to-earnings-growth ratio of 0.73 and a beta of 0.49.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. During the same quarter last year, the business earned $1.19 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.8%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.